TLX•globenewswire•
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
Summary
MELBOURNE, Australia and INDIANAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA (U.S.).
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 8, 2026 by globenewswire